ESR1 and breast cancer: Knockdown of these proteins, achieved by using pre-designed silencing RNAs (siRNA), affected cell proliferation and migration, expression of cell adhesion molecules, and focal adhesion formation resulting in an inhibition of neutrophil-mediated dissemination of ER+ BC cells in vivo.